Immudex is hosting a live webinar on Tuesday, 29 September 2026, titled Immudex Live Webinar: Decoding Human CMV-Specific CD8⁺ Cells through Multi-Layered Single-Cell Microscopy

Public source

Publisher name

Public post

🔬 Register now for the 𝐈𝐦𝐦𝐮𝐝𝐞𝐱 𝐋𝐢𝐯𝐞 𝐖𝐞𝐛𝐢𝐧𝐚𝐫: “𝐃𝐞𝐜𝐨𝐝𝐢𝐧𝐠 𝐇𝐮𝐦𝐚𝐧 𝐂𝐌𝐕-𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐂𝐃𝟖⁺ 𝐓 𝐂𝐞𝐥𝐥𝐬 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐌𝐮𝐥𝐭𝐢-𝐋𝐚…

Log in to read the full post

Company

Immudex

Decipher Adaptive Immunity

Industry
Biotechnology Research
Location
Copenhagen, DK
Company size
11–50 employees

About Immudex

Immudex is a life science company and trusted partner of scientists spearheading the global adoption of precision immune monitoring. Immudex’s Dextramer® technology enables superior detection of antigen-specific immune cells. Immudex’s product portfolio allows scientists to investigate diverse types of immune cells, including T cells, non-conventional T cells, B cells and CAR cells using flow cytometry, next generation sequencing and single-cell multi-omics.

See more

Latest activity

2 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.